AZTR: Planning 2nd Site for ATR-12 Trial
Azitra is developing genetically engineered bacteria for therapeutic use in dermatology. The company possesses a microbial library of 1,500 unique...
AZTR: First ATR-12 Patient Screened
Azitra is developing genetically engineered bacteria for therapeutic use in dermatology. The company possesses a microbial library of 1,500 unique...
AZTR: Initiation - Get Some Skin in the Game
The company possesses a microbial library of 1,500 unique bacterial strains that are candidates for a variety of indications.
No more insights